Sozinibercept (Anti-VEGF-C/-D) Combined with Ranibizumab for Polypoidal Choroidal Vasculopathy: Phase IIb Predefined Subgroup Analysis

Purpose: The aim of this study was to assess the efficacy of sozinibercept, a novel “trap” inhibitor of VEGF-C and VEGF-D, when combined with ranibizumab for the treatment of polypoidal choroidal vasculopathy (PCV). Design: Prespecified subgroup analysis of a randomized, double-masked, sham-controll...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Chui Ming Gemmy Cheung, MD, FRCOphth, Timothy L. Jackson, PhD, FRCOphth, Charles C. Wykoff, MD, PhD, Arshad M. Khanani, MD, FASRS, Ian M. Leitch, PhD, Megan E. Baldwin, PhD, Jason Slakter, MD
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2025-07-01
Edice:	Ophthalmology Science
Témata:	Neovascular age-related macular degeneration Polypoidal choroidal vasculopathy Sozinibercept VEGF-C/-D
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2666914525000570
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!